BECTON, DICKINSON AND COMPANY

(BDX)
  Report
Delayed Nyse  -  04:00 2022-08-11 pm EDT
259.40 USD   +0.32%
04:50pBECTON DICKINSON AND : Statement of Changes in Beneficial Ownership - Form 4
PU
08/09BECTON DICKINSON & CO : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/09Becton, Dickinson and Company, Labcorp Collaborate to Develop Flow Cytometry-Based Companion Diagnostics for Matching Patients with Treatments
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Sector news Other Medical Equipment, Supplies & Distribution
08/08France's Sartorius Stedim Biotech To Buy UK-based Albumedix For $501 Million
MT
08/08Sartorius Stedim Biotech S.A. entered into a definitive agreement to acquire Albumedix ..
CI
08/04Abbott and Weightwatchers Partner to Support People Living with Diabetes in Attaining T..
CI
08/04HOYA Corporation announces an Equity Buyback for 5,200,000 shares, representing 1.44% f..
CI
08/04HOYA Corporation authorizes a Buyback Plan.
CI
08/01Abbott Laboratories Announces Executive Changes
CI
07/28INSIDER SELL : Abbott Laboratories
MT
07/27UBS Adjusts Abbott Laboratories Price Target to $128 From $142, Maintains Buy Rating
MT
07/27Danone sends 1.3 million cans of Aptamil formula to U.S. amid shortage
RE
07/27France's Danone raises sales outlook despite hiking prices
RE
07/26Abbott Introduces Canada's First Remote Neuromodulation Patient-Care Technology, NeuroS..
CI
07/26ANALYST RECOMMENDATIONS : Microsoft, UnitedHealth, American Express, EOG Resources, Haleon..
MS
07/25Goldman Sachs Adjusts Abbott Laboratories' Price Target to $104 From $111, Maintains Se..
MT
07/22SARTORIUS STEDIM BIOTECH : Buy rating from Berenberg
MD
07/22SARTORIUS STEDIM BIOTECH : Receives a Buy rating from JP Morgan
MD
07/21Morgan Stanley Trims Price Target on Abbott Laboratories to $132 From $134, Reiterates ..
MT
07/21Abbott Laboratories' PT From RBC Cut to $132 From $143 Despite Q2 Beat, Cites Foreign E..
MT
07/21TRANSCRIPT : Sartorius Stedim Biotech S.A., Q2 2022 Earnings Call, Jul 21, 2022
CI
07/21Citigroup Trims Price Target on Abbott Laboratories to $123 From $125, Reiterates Buy R..
MT
07/21Correction to Sartorius Earnings Article
DJ
07/21Life Sciences Group Sartorius' H1 Profit Rises Amid Strong Underlying Industry Demand
MT
07/21Sartorius Stedim Biotech Posts 77% Surge In H1 Profit On Organic Sales Revenue Growth; ..
MT
07/21Sartorius confirms 2022 outlook on strong H1 sales
RE
07/21Sartorius 1st Half Profit Rose As Sales Grew
DJ
07/20Sartorius Stedim Biotech S.A. Reports Earnings Results for the Second Quarter and Six M..
CI
07/20Truist Securities Lowers Medtronic's Price Target to $97 From $111, Hold Rating Maintai..
MT
07/20Abbott Raises 2022 Outlook on Improved Second-Quarter But Revenue Excluding COVID-19 Te..
MT
07/20SECTOR UPDATE : Health Care Stocks Mixed Premarket Wednesday
MT
07/20TRANSCRIPT : Abbott Laboratories, Q2 2022 Earnings Call, Jul 20, 2022
CI
07/20Abbott Labs Raises FY22 Earnings Guidance
DJ
07/20Abbott Labs Posts Higher 2Q Profit, Sales
DJ
07/20Abbott Laboratories Reports Higher Adjusted Q2 Profit, Sales; Raises Full-Year 2022 Out..
MT
07/20Abbott aims to recapture baby formula market share
RE
07/20Abbott Laboratories Raises Earnings Guidance for 2022
CI
07/20Earnings Flash (ABT) ABBOTT Posts Q2 Revenue $11.26B
MT
07/20Earnings Flash (ABT) ABBOTT Posts Q2 EPS $1.43
MT
07/20Abbott Laboratories Reports Earnings Results for the Second Quarter and Six Months Ende..
CI
07/19Goldman Sachs Adjusts Medtronic's Price Target to $96 From $112, Reiterates Neutral Rat..
MT
07/19Hoya Concludes $436 Million Share Buyback
MT
07/19Tranche Update on HOYA Corporation's Equity Buyback Plan announced on May 6, 2022.
CI
07/18Stifel Nicolaus Adjusts Medtronic's Price Target to $105 From $125, Maintains Buy Ratin..
MT
07/18Stifel Nicolaus Adjusts Abbott Laboratories' Price Target to $126 From $136, Reiterates..
MT
07/18BTIG Lowers Abbott Laboratories' Price Target to $126 From $130, Maintains Buy Rating
MT
07/15Morgan Stanley Lowers Medtronic's Price Target to $103 From $114, Maintains Equalweight..
MT
07/15Morgan Stanley Adjusts Price Target on Medtronic to $103 From $114, Keeps Equalweight R..
MT
07/15Raymond James Adjusts Abbott Laboratories' Price Target to $117 from $135, Keeps Outper..
MT
07/15Medtronic to Expand Colon Cancer Screening Program With Support From Amazon Web Service..
MT
07/15Morgan Stanley Lowers Abbott Laboratories' Price Target to $134 From $145, Maintains Ov..
MT
07/15TRANSCRIPT : Medtronic plc - Special Call
CI
07/15HOYA Corporation's Equity Buyback announced on May 6, 2022, has expired with 4,703,700 ..
CI
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on BECTON, DICKINSON AND COMPANY